Description
Reneuro (Choline Alfoscerate) Solution for Injections 250 mg/ml. 4 ml Ampoules №10
Ingredients:
- Each 4 ml ampoule contains 1000 mg of Choline Alfoscerate.
Dosage:
The recommended dosage is determined by a healthcare professional based on individual needs. Reneuro is typically administered via intramuscular or intravenous injection.
Indications:
Reneuro is indicated for the treatment of cognitive disorders and memory impairment associated with various conditions. It may also be used in the management of certain neurological disorders.
Contraindications:
Do not use Reneuro if you are allergic to choline alfoscerate or any other ingredients in the solution. It is important to consult with a healthcare provider before starting treatment.
Directions:
Administer Reneuro as directed by a healthcare professional. The solution should be visually inspected for particulate matter and discoloration before administration.
Scientific Evidence:
- Choline alfoscerate, the active ingredient in Reneuro, has been studied for its cognitive-enhancing properties.
- Research suggests that choline alfoscerate may improve memory, attention, and overall cognitive function.
- In a double-blind, placebo-controlled study published in the Journal of Clinical Psychopharmacology, choline alfoscerate was found to significantly improve cognitive performance in patients with cognitive impairment.
Additional Information:
- Reneuro is well-tolerated in most individuals, with minimal side effects reported.
- However, it is essential to discuss any existing medical conditions or medications with a healthcare provider before using Reneuro.
- For more information on the pharmacological effects and clinical trials of Reneuro, consult published research studies and medical literature for comprehensive insights into its efficacy and safety profile.
